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ABSTRACT
It has been hypothesized that a replication asso-
ciated repair pathway operates on base damage
and single strand breaks (SSB) at replication forks.
In this study, we present the isolation from the
nuclei of human cycling cells of a multiprotein
complex containing most of the essential compo-
nents of base excision repair (BER)/SSBR, including
APE1, UNG2, XRCC1 and POLb, DNA PK, replicative
POLa, d and e, DNA ligase 1 and cell cycle regulatory
protein cyclin A. Co-immunoprecipitation revealed
that in this complex DNA repair proteins are
physically associated to cyclin A and to DNA
replication proteins including MCM7. This complex
is endowed with DNA polymerase and protein
kinase activity and is able to perform BER of uracil
and AP sites. This finding suggests that a pre-
assembled DNA repair machinery is constitutively
active in cycling cells and is ready to be recruited at
base damage and breaks occurring at replication
forks.
INTRODUCTION
Both DNA replication and repair are performed by
multiprotein assemblies and share common features.
DNA repair must be coordinated with DNA replication
in order to avoid ﬁxation of DNA damage into heritable
mutations. A fundamental level of cross-talk between
DNA replication and DNA repair is ensured by the fact
that the enzymes active in replicating DNA during
S phase are also needed to synthesize new stretches of
DNA during various types of repair including nucleotide
excision repair (NER), mismatch repair (MMR), single-
strand DNA break repair (SSR) and base excision repair
(BER). An additional level of coordination is needed to
achieve integration of the DNA repair and DNA
replication protein networks within the highly sophisti-
cated cell cycle regulatory machinery. Indeed, many
components of the DNA replication machinery associate
with other factors such as cyclins/Cdks in dynamic
multiprotein complexes that regulate cell cycle progres-
sion. The so-called cyclin-dependent protein kinase (Cdk)-
driven ‘replication switch’ model predicts that cyclin/Cdk
complexes function both to activate initiation complexes
assembled at the origins and to inhibit further complex
assembly during S-phase, thus preventing unscheduled re-
replication (reviewed in (1)).
BER counteracts the cytotoxic and mutagenic eﬀects of
most endogenously produced DNA damage. Its role must
be critical when this type of damage is produced or
persists at replication forks. In BER, speciﬁc DNA
glycosylases are responsible for base removal followed
by formation of a single strand break (SSB) by an AP
endonuclease. SSB that arise directly from sugar damage
usually possess non-conventional termini that need
further processing to allow completion of SSB repair
(SSBR). In both BER and SSBR the resulting gap is ﬁlled
by DNA polymerase (POL)b (short-patch repair) or by
POLb/d/e (long-patch repair). Additional players in
long-patch repair are replication factor (RF) C, prolifer-
ating cell nuclear antigen (PCNA) and ﬂap endonuclease-
1 (FEN1). The ﬁnal ligation step is then operated by the
XRCC1/DNA ligase IIIa (LIG3) complex or DNA ligase
I (LIG1) in the short- and long-patch pathways,
respectively (reviewed in (2)). Interestingly, PCNA, that
is involved in the dynamic assembly and disassembly of the
DNA replication machinery, has been shown to interact
with several BER/SSBR proteins such as adenine DNA
glycosylase (MYH) (3), uracil DNA glycosylase UNG2,
5’ AP endonuclease APE1, XRCC1, POLb,P O L d,
FEN1and LIG1 (reviewed in (4)). Based on these ﬁndings,
it has been hypothesized that there is a BER/SSBR
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and employs proteins like PCNA, FEN1, LIG1 and
POLd/e that are in common with the replication
machinery (5–7).
A growing body of evidence indicates that BER/SSBR
proteins are regulated by post-translational modiﬁcation
and make physical interactions with components of other
DNA transaction pathways (reviewed in (8)). One of the
most compelling evidence of BER regulation via post-
translation modiﬁcations is the phosphorylation in vitro
and in vivo by Casein Kinase 2 of one of the central players
of BER, the scaﬀold protein XRCC1 (9). This phosphory-
lated form promotes a more eﬃcient SSBR. Another
example is the homeostatic regulation of BER by a p53-
induced phosphatase, PPM1D, that suppresses BER by
dephosphorylation of the nuclear isoform of uracil DNA
glycosylase, UNG2 (10).
It should be taken into account that most of our
knowledge about BER has been derived from studies
carried out in vitro by using mammalian cell extracts or
puriﬁed proteins and synthetic DNA molecules containing
single lesions. However, an open question is how cross-
talk between DNA replication and DNA repair machi-
neries is achieved at the cellular and molecular level. The
analysis of the protein–protein interactions within BER
proteins and between BER and other pathways occurring
in the cell is a prerequisite to better understand the
regulation of the DNA repair processes in the context of
the cell cycle.
In this study, we present the isolation from the nuclei of
human cycling cells of a complex containing most of the
essential components of BER physically associated to
cyclin A and to DNA replication proteins. This complex is
endowed with a protein kinase activity and is able to
perform BER of uracil residues as well as of apurinic/
apyrimidinic (AP) sites via both short- and long-patch
BER. The fact that this complex was isolated from human
cells in the absence of any DNA-damaging treatment,
suggests that a preassembled BER machinery is constitu-
tively active in the cycling cells and is ready to be recruited
to the site of damage likely to occur at the replication
forks.
MATERIALS AND METHODS
Chemicals
Restriction enzymes and T4 polynucleotide kinase were
from New England Biolabs. T4 DNA polymerase
holoenzyme, T4 single-stranded DNA binding protein,
T4 DNA ligase and dNTPs were purchased from Roche
Molecular Biochemicals. Both oligodeoxyribonucleotides
containing a single uracil: 50-GATCCTCTAGAGUCGA
CCTGCA-30 (for preparation of circular duplex DNA
substrate) and 5’-GATCCTCTAGAGUCGACCTGCAG
GCATGCA-3’ (for incision assay), were synthesized by
MWG-Biotech AG. Ugi was kindly provided by
S.E. Bennett (Oregon State University, Corvallis, OR,
USA). [g-
32P] ATP was from GE Healthcare and [a-
32P]
dCTP and [a-
32P]dTTP were from Perkin Elmer.
Nitrocellulose membranes (HybondECL) were from GE
Healthcare. GF/C ﬁlters were from Schleicher & Schuell.
Olomucine and aphidicolin were from Sigma. All other
reagents were purchased from BioRad, Sigma, Fluka,
Gibco and BDH.
Cells and media
HeLa cells were grown in DMEM supplemented with
10% FCS, 50mg/ml gentamycin and 2mM L-Glutamine,
at 378C and 5% CO2. Cells were pelleted by centrifugation
and stored in aliquots at  808C until used.
SV40 transformed wild-type and POLb-null mouse
embryonic ﬁbroblasts (MEFs) (a gift from Dr S.H.
Wilson, NIEHS, Research Triangle Park, NC) were
cultured in DMEM supplemented with Glutamax-1,
10% FCS, 100U/ml penicillin, 100mg/ml streptomycin
and 80mg/ml hygromycin at 348C and 10% CO2.
Protein purification
The puriﬁcation was performed essentially as
described (11), with the following modiﬁcations. After
the size exclusion chromatography, the pooled fractions
were loaded onto a hydroxyapatite column, equilibrated
in Buﬀer F (25mM Bis-Tris pH 6.6, 50mM NaCl, 0.5mM
ATP, 1mM DTT, 5% glycerol, 1mM PMSF and protease
inhibitors). The column was eluted with a linear gradient
from 0.1 to 1M phosphate buﬀer pH6.6. The active
fractions were pooled, diluted in Buﬀer F to bring the
potassium phosphate below 0.1M and then loaded onto a
Mono S column (Pharmacia) equilibrated in Buﬀer F.
The column was eluted with a linear gradient from 0.1 to
1M NaCl.
Immunoprecipitation experiments
The Mono S fraction 15 (5mg) was adjusted to 10mM
Tris-HCl pH 7.4, 50mM NaCl, 2.5mM MgCl2 and
protease inhibitors and then incubated for 1h at 48C
with protein A-sepharose beads (BioRad) equilibrated in
the same buﬀer and previously coupled to the appropriate
antibodies, as indicated in the ﬁgure legends. After
centrifugation the pellet was washed with equilibration
buﬀer containing 80mM NaCl and the immunoprecipi-
tated material was analysed by western blot.
Wild-type or POLb-null MEFs (4 10
7) were lysed in
the presence of 10mM Tris-HCl pH 7.4, 150mM NaCl,
2.5mM MgCl2 and protease inhibitors for 30min on ice
and then homogenized by dounce. After centrifugation at
20000 g at 48C, the supernatant (crude extract) was
diluted two times in the same buﬀer without NaCl and
incubated for 1h at 48C with protein A-sepharose beads
(BioRad) equilibrated in the same buﬀer and previously
coupled to the appropriate antibodies, as indicated in the
ﬁgure legends. After centrifugation the pellet was
washed with the same buﬀer containing 80mM NaCl
and the immunoprecipitated material was analysed by
western blot.
Native gelelectrophoresis
Mono S fraction 15 (5–10mg) was resolved on a 5%
native polyacrylamide gel in the absence of SDS and
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at 48C. Samples were transferred to nitrocellulose
membrane at 12V for 12–16h at 48C and subjected to
western blot analysis.
Gel filtration
Mono S fraction 15 (20mg) was applied to a Superdex200
10/300 GL gel ﬁltration column equilibrated with 10mM
Tris-HCl pH 7.4, 80mM NaCl, 2.5mM MgCl2 and
protease inhibitors. The column was eluted with the
same buﬀer and the eluted fraction analysed by dot blot
immunoassay and western blot. Molecular weight
markers used for column calibration were ferritin
(440 kDa), catalase (232 kDa), lactate dehydrogenase
(140 kDa) and BSA (66 kDa).
Protein kinase assays
The assay was carried out in ﬁnal volume of 10ml
containing 0.15mg of Mono S fraction 14, 50mM
Tris-HCl pH 7.5, 10mM MgCl2, 0.5mM[ g-
32P] ATP
(3000Ci/mmol). Reactions were supplemented, when
indicated, with 0.4mg/ml histone H1, 0.5mM
Olomucine or recombinant p21
cip/WAF. Samples were
incubated for 20min at 378C and loaded onto a 10%
SDS-PAGE. Gels were quantiﬁed by PhosphorImager
(Typhoon, GE Healthcare).
Antibodies
Anti-FEN1, anti-UDG, anti-POLa,P O L d,P O L e,a n t i -
cyclin B and E, anti-MCM7 and anti-APE1 were from
Santa-Cruz Biotechnology. Anti-cyclin A and anti-
phosphoSer/Thr were from Sigma. Anti-XRCC1 was
from Trevigen. Anti-DNAPK was from Calbiochem.
Anti-POLb was kindly provided by S.H. Wilson (NIEHS,
Research Triangle Park, NC, USA) and anti-POLi by T.A.
Kunkel (NIEHS, Research Triangle Park, NC, USA). Anti-
LIG1 was a kind gift of A. Montecucco (IGM-CNR, Pavia,
Italy) and anti-POL  was kindly provided by U. Hu ¨ bscher
(University of Zu ¨ rich-Irchel, Switzerland).
Preparation and characterization ofcircular duplex
DNA substrates
Closed circular DNA molecules containing a single lesion
were produced as described previously (12) by priming
single-stranded (þ) pGem-3Zf(þ) DNA (Promega) with
the oligonucleotides containing the lesion of interest.
In vitro DNA synthesis was performed by using T4 DNA
polymerase holoenzyme, single-stranded DNA binding
protein, dNTPs and T4 DNA ligase. Closed circular DNA
duplex molecules were puriﬁed by cesium chloride
equilibrium centrifugation. Plasmid DNA molecules con-
taining a single uracil residue were digested with E. coli
uracil DNA glycosylase (Trevigen) to produce abasic sites.
Repair assay
Repair reactions were carried out as described in (12).
Brieﬂy, reaction mixtures (50ml) contained 40mM
HEPES/KOH (pH 7.9), 75mM KCl, 5mM MgCl2,
0.5mM dithiothreitol, 50mM of each dNTP, 2mCi of
[a-
32] P dCTP or [a 
32] P dTTP as indicated, 2mM ATP,
40mM phosphocreatine, 2.5mg of creatine phosphokinase
(type I, Sigma), 3.4% glycerol, 18mg of bovine serum
albumin and 5ml of the isolated multiprotein complex
(Mono S fraction 14, 1mg of total proteins) were
incubated 1h at 308C. Depending on the labelled dNTP
used in the repair mix, the concentration of the
corresponding cold dNTP was decreased to 5mM. When
the assay was performed in the presence of aphidicolin,
a concentration of 300mM was used. The repair products
were digested with appropriate restriction enzymes,
resolved on a denaturing 20% PAGE and quantiﬁed by
electronic autoradiography (Instant Imager, Packard).
Incision assay
(g-
32P)-labelled 30-mer oligonucleotides containing
a single uracil were annealed with the appropriate
complementary oligonucleotide to obtain U/A-containing
duplexes. Following 1h incubation at 378C with the
complex (Mono S fraction 14, 1mg of total proteins)
in 25mM Tris-HCl pH 7.6, 1mM EDTA, 50mM NaCl,
the incision products were incubated for 10min at 958Ci n
the loading buﬀer (formammide 95%, EDTA 20mM,
bromophenol blue 0.05%, xylene cyanol FF 0.05%),
resolved on a denaturing 20% PAGE and quantiﬁed by
electronic autoradiography (Instant Imager, Packard).
RESULTS
Isolationof amultiprotein complexfrom HeLa cells
containing DNA replication proteins, cell cycle
regulatory factorsand baseexcision repair proteins
HeLa cell nuclei were isolated and fractionated according
to a procedure already established in our laboratory to
isolate multiprotein complexes (11). During the fractiona-
tion procedure, DNA polymerase activity was measured
using three diﬀerent assays, one speciﬁc for POLa
(activated DNA) another one for POLd and POLe
(poly(dA)/oligo(dT) in the presence of PCNA) and a
third one for POLa and POLe (poly(dA)/oligo(dT) in the
absence of PCNA). Co-puriﬁcation of other DNA
replication and cell cycle regulatory factors was monitored
by a dot blot immunoassay. Figure 1 shows the elution
proﬁle of the last puriﬁcation step (Mono S column). A
peak of DNA polymerase activity was observed between
fraction 10 and 20 with both assays (Figure 1A). Further
characterization revealed the presence of 30–50 exonuclease
activity, DNA helicase activity and histone H1 phosphor-
ylation activity (data not shown and Figure 2). The
presence of POLa and POLd and, in addition, LIG1 and
cyclin A in the same fractions was conﬁrmed by dot blot
(Figure 1B). A slightly diﬀerent elution proﬁle was
revealed at the tails of the peak (fractions 10–12 and 20–
24, Figure 1) between cyclin A and the other proteins. This
could be either due to diﬀerent isoelectric points and/or
diﬀerent sensitivities of the antibodies used. The central
peak fractions (14 and 15) were used for all the subsequent
experiments. Next, the isolated complex (Mono S fraction
14) was analysed with a panel of poly- and monoclonal
antibodies directed against a number of DNA replication
Nucleic Acids Research, 2007, Vol. 35, No. 5 1571and repair proteins. As shown in Figure 3, western blot
analysis revealed the presence in the same fraction of four
diﬀerent DNA polymerases (POLa, POLb, POLd and
POLe) and, in addition, LIG1, UNG2, XRCC1, DNA-
dependent protein kinase (DNA PK) and cyclin A. We
could not detect other factors such as cyclin B, cyclin E,
PCNA, POL  or POLi (data not shown). Analysis of the
composition of the Mono S fraction 15 gave perfectly
comparable results, indicating that these two peak
fractions represent a homogeneous preparation (data not
shown).
TheDNAreplication,DNArepairandcellcycleproteinsofthe
isolated complexare physically associated
In order to test whether these proteins were physically
associated, we used three diﬀerent approaches:
co-immunoprecipitation (co-IP), native gel electrophoresis
and gel ﬁltration. We tested all our antibodies for
immunoprecipitation. The best results were obtained
with anti-cyclin A monoclonal antibodies, which were
then used for the analysis of the peak fraction 15. As
shown in Figure 4A, anti-cyclin A antibodies were able to
eﬃciently immunoprecipitate cyclin A from the Mono S
peak fraction. In addition, several proteins were found to
co-immunoprecipitate together with cyclin A: POLe,
XRCC1, LIG1, APE1, UNG2 and POLb. As controls,
we performed the reciprocal co-IPs for some of these
interactions and we found that LIG1, cyclin A and POL"
were co-IPed together with POLb by anti-POLb anti-
bodies, whereas POLb and cyclin A were co-IPed together
with POLe by anti-POLe antibodies. As an additional
control, POLb-null or wild-type cells (MEFs) were lysed
and subjected to immunoprecipitation with anti-POLb
antibodies. Immunoprecipitated material was analysed
with anti-POLb and anti-LIG1 antibodies. As shown in
Figure 4A, right panel, only in the POLb wild-type cells
LIG1 could be co-immunoprecipitated with POLb,
whereas no immunoprecipitated proteins were detected
in POLb-null cells. The Mono S fraction was analysed by
native gel electrophoresis. As shown in Figure 4B,
antibodies directed against POLb, POLe, POLa, LIG1
and XRCC1, all reacted with a single band in the high
molecular weight range (apparent Mr4669 kDa). In
order to further conﬁrm the physical association of these
proteins, the Mono S fraction 15 was subjected to gel
ﬁltration. Figure 4C shows the dot blot immunoassay of
Figure 1. Puriﬁcation of the multiprotein DNA repair complex. (A) Elution proﬁle of the last puriﬁcation step (Mono S). POLa (black symbols),
POLa/e (open squares) and POLd/e (open triangles) activities coeluted in the same fractions. (B) Dot blot analysis of the Mono S fractions with
speciﬁc antibodies showing coelution of cyclin A, POLa, POLd and LIG1.
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and cyclin A coeluted together in fractions 10–12,
corresponding to an apparent molecular mass4440kDa,
as expected from a multiprotein complex. We tested,
in addition, the presence of another DNA replication
associated protein, MCM7, and we found that it was
coeluting together with POLa, LIG1 and cyclin A,
indicating its association to the complex. The gel ﬁltration
fraction 10 was further analysed by western blot.
As shown in Figure 4D, POLa, POLb, POLd, LIG1,
DNA PK, cyclinA and MCM7, were detected in the same
fraction.
All together, these results suggested that we
have isolated a multiprotein complex containing
DNA replication, DNA repair and cell cycle regulatory
proteins.
The multiprotein complex isactive in baseexcision repair
In order to verify the repair capacity of the replication
complex an in vitro BER assay was performed by using,
as substrate, a plasmid containing either an AP site
or a single uracil residue. Following incubation of
the plasmid with the multiprotein complex (Mono S
fraction 14), the total DNA repair events (short- and
long-patch repair events) were measured by [a-
32P] dTTP
incorporation in restriction fragment A, whereas incor-
poration of [a-
32P] dCTP in fragment B corresponded
exclusively to the long-patch repair events (see scheme,
Figure 5 bottom). As shown in Figure 5 the AP site was
repaired predominantly via short-patch pathway, with a
fraction (25% of total) of long-patch repair events also
occurring, which were largely aphidicolin-sensitive (lanes 2
and 4). Addition of PCNA increased incorporation in
both A and B fragments (lanes 5 and 6) and this increase
was abolished by aphidicolin (lanes 7 and 8), suggesting a
role for the PCNA-dependent and aphidicolin sensitive
enzymes POLd/POLe in the repair process. Interestingly,
inhibition of POLb by speciﬁc antibodies, resulted in a
switch from short- to long patch, as indicated by the
increase of incorporation in fragment B (lanes 9 and 10).
When similar experiments were performed with a uracil-
containing oligonucleotide (Figure 6A), the isolated
complex showed uracil excision activity (lane1). This
cleavage activity was due to UNG2 as demonstrated by its
Figure 2. Protein kinase activity of the multiprotein complex.
(A) Phosphorylated polypeptides were revealed upon incubation of
the Mono S fraction in the presence of [g-32P] ATP alone (lane 1), or
in combination with histone H1 (lane 2), histone plus p21 (lane 3) or
histone plus Olomucine (lane 4). (B) The Mono S fraction was
immunoprecipitated with anti-cyclin A antibodies and the immunopre-
cipitated material was probed with antibodies against cyclin A (lane 1)
or anti-phosphoSer/Thr (lane 2).
Figure 3. Western blot analysis of the Mono S fraction. The peak
fraction 14 from Mono S was analysed by immunoblotting with
diﬀerent antibodies against DNA repair and replication proteins, as
described in material and method section. A single asterisk indicates
the expected polypeptide, whereas double asterisk mark indicates
degradation products.
Nucleic Acids Research, 2007, Vol. 35, No. 5 1573Figure 4. Physical association of DNA replication and repair proteins. (A) Left panel: The Mono S fraction 15 was immunoprecipitated with
antibodies against cyclin A, POLb, POLe or anonymous IgGs. Right panel: POLb null ( / ) or wild type (þ/þ) mouse embryonic ﬁbroblasts were
lysed and the extracts used for immunoprecipitation in the presence of anti-POLb antibodies. The immunoprecipitated material was then
immunoblotted with anti-POLb and anti-LIG1 antibodies, as indicated. S, supernatant (1:10); IP, immunoprecipitated material. (B) The Mono S
fraction 15 was subjected to native gel electrophoresis, followed by immunoblotting analysis with antibodies against POLa, POLb, POLe, LIG1 and
XRCC1. As marked by the asterisks, all the antibodies recognized the same high molecular weight band. (C) The Mono S fraction 15 was subjected
to gel ﬁltration. Eluted proteins were analysed by dot blot with antibodies against POLa, LIG1, Cyclin A and MCM7. Arrows indicate the
corresponding elution points of the molecular weight markers. (D) The gel ﬁltration fraction 10 was analysed by western blot with antibodies against
POLa, POLb, POLd, DNA PK, cyclin A and MCM7.
1574 Nucleic Acids Research, 2007, Vol. 35, No. 5speciﬁc inhibition by Ugi (lane 2) (13). The multiprotein
complex performed BER of the uracil paired with adenine
(Figure 6B) prevalently by short-patch pathway with 35%
of the total repair events involving the replacement of
more than one nucleotide (long- patch BER). The complex
was unable to incise duplex oligonucleotides containing
8-oxo-7,8-dihydroguanine/A (8-OH-G/A) and 5-hydroxy-
uracil (5-OHU/A) mismatches indicating the absence of
MYH and NEIL1 activities (data not shown).
The multiprotein complexis endowedwith aproteinkinase
activity and containstwo major phosphorylatedspecies
Since the multiprotein complex isolated here contained
cyclin A, which is the regulatory subunit of cyclin-
dependent protein kinases (cdks), we tested whether this
complex displayed cdk activity. As a reference substrate
we used histone H1. As shown in Figure 2A, lane 1,
incubation of the puriﬁed complex (Mono S fraction 14)
in the presence of [g-
32P] ATP resulted in the appearence
of two major phosphorylated polypeptides, one with an
apparent MW of 110–120kDa (high molecular weight
phosphopeptide, HMP) and one with an apparent MW of
50kDa (low molecular weight phosphopeptide, LMP).
Addition of histone H1 to the reaction resulted in the
appearance of an additional product at the expected
position for phosphorylated H1 (lane 2). When the
reaction was complemented with either the kinase
inhibitor Olomucine (lane 4) or the speciﬁc cdk inhibitor
protein p21 (lane 3), all phosphorylated products were
greatly reduced, suggesting that they were phosphorylated
by a cyclin A/cdk complex. In order to prove the physical
association of the HMP and LMP proteins with the
complex, a co-immunoprecipitation experiment was per-
formed with anti-cyclin A antibodies. As shown in
Figure 2B, lane 1, cyclin A was successfully immunopre-
cipitated. When the same sample was probed with a
cocktail of antiphosphoserine–threonine antibodies, two
bands appeared, with apparent MW identical to the LMP
and HMP proteins detected by the kinase assay
(Figure 2B, lane 2). According to its apparent electro-
phoretic mobility, the LMP protein appears to be distinct
from cyclin A (Figure 2B, compare lane 1 with lane 2).
These results seem to indicate that two major phospho-
peptides are physically associated to the isolated complex
and are likely phosphorylated by cyclin A/cdk. The precise
identity of these two proteins is under investigation.
In summary, the multiprotein complex presented here
contains an active cyclinA/cdk complex which is able to
phosphorylate some components of the complex itself.
DISCUSSION
The mammalian genome is constantly subjected to
chemical alterations ( 10
6 modiﬁcations per day) that
have the potential to cause genome instability. Particular
vulnerability exists during replication when attempted
Figure 5. Mapping of the repair patches at AP site by the multiprotein
complex. Top: autoradiograph of a denaturing polyacrylamide gel.
Bottom: sequence of the restriction fragments A and B. Repair
reactions were performed for 1h in the presence of radiolabelled dTTP
(lanes 1-3-5-7-9) or dCTP (lanes 2-4-6-8-10). Aphidicolin (APH),
PCNA and a-POLb were added as indicated. IS, internal standard.
Figure 6. Incision and repair activity at uracil by the multiprotein
complex. (A) Incision assay in the absence (lane 1) or presence (lane 2)
of the UNG2 inhibitor Ugi. (B) Repair assay in the presence of
radiolabelled dTTP (lane 1) or dCTP (lane 2). Bottom: sequence of the
restriction fragments A and B. IS, internal standard.
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dangerous lesions such as double strand breaks. To
counteract these threats, cells are provided with sophisti-
cated systems that sense DNA damage and coordinate its
repair. Of particular importance for the removal of
damaged bases from the DNA is the BER system (2).
Although BER can be reconstituted in vitro with a few
essential components, numerous studies have revealed
that physical and/or functional protein–protein interac-
tions occur at virtually every step of the BER process.
These interactions involve not only the classical BER
proteins, but also proteins associated with other DNA
transaction pathways. These interactions could play
diﬀerent roles including: (i) stabilizing the associated
repair protein; (ii) recruiting speciﬁc partners to the
damaged site for lesion repair; (iii) altering enzymatic
function or activity; and (iv) coordinating BER with other
pathways of DNA metabolism. Thus, physical contact
between proteins does not always result in a change in the
enzymatic activity of the proteins involved, and for this
reason it might even go undetected by in vitro enzymatic
studies.
Here, we demonstrated the existence in human cells of a
preassembled multiprotein complex containing cyclin A,
DNA replication proteins and BER/SSBR components.
Also one component of DSB repair, DNA PK, is present
in this complex. Interestingly, the DNA PK/Ku70/Ku80
heterotrimeric complex that contributes to the resolution
of DSB has been recently shown to interact with XRCC1
and stimulates its phosphorylation (14). Since we isolated
this complex from nuclei of proliferating human cells
without prior treatment with DNA- damaging agents, it
seems that the presence of this complex is independent of
damaged DNA. However, we cannot exclude that the
basal physiological level of DNA damage might be
enough to trigger complex formation. The isolation from
undamaged cells of multiprotein BER/SSBR complexes
by diﬀerent methods has been previously reported (15–18).
In 1996, Prasad et al. (15) reported the isolation by a
POLb aﬃnity method of a complex of a molecular mass of
 180kDa from bovine testis that contained POLb, LIG1
and UNG2. Whitehouse et al. and Luo et al. demon-
strated that XRCC1 protein is in complex with LIG3,
PNK and POLb (16,17). An alternative complex com-
prises XRCC1, LIG3 and aprataxin (16). Akbari et al. (18)
isolated a repair complex (UNG2–ARC) that contains
UNG2, APE1, POLb, XRCC1, PCNA and LIG1 by using
antibodies speciﬁc for the N-terminal non- catalytic
domain of UNG2. More recently an interphase-speciﬁc
XRCC1 complex has been described: it comprises PARP1,
FEN1, POLd and condensin, a factor well known to be
essential in mitotic chromosome organization (19).
Including this study, BER complexes have been isolated
by six diﬀerent methods indicating that these complexes
are stable and DNA damage recognition by the DNA
glycosylase is not required to trigger complex formation.
In vivo large foci containing XRCC1, a key player of
BER/SSBR, have been described both in undamaged (20)
and irradiated (21–22) cells. As expected, there is
signiﬁcant overlapping between the BER components
contained in the UNG2-ARC complex (18) and those
identiﬁed in our complex. Our complex contains UNG2 as
the only uracil DNA glycosylase, as shown by the
complete inhibition of uracil cleavage in the presence of
Ugi, as well as APE1, LIG1 and XRCC1. However, in
addition to UNG2, APE1, LIG1, XRCC1, POLb and
POLd, we identiﬁed two additional DNA polymerases,
namely POLa and POLe POLd and POLe have been
already suggested to take part in the long-patch BER
(reviewed in (2)). Accordingly, our isolated complex was
able to perform both short- and long-patch BER at AP
sites with the short patch BER as the predominant
pathway. Addition of PCNA and/or inhibition of Polb
switched the equilibrium in favour of long-patch repair
products, whereas addition of aphidicolin resulted in the
opposite eﬀect. This reﬂects an intrinsic ability of the
complex to respond to exogeneous stimuli (such as the
presence of PCNA and/or limiting POLb activity). We did
not ﬁnd PCNA associated to our complex. It must be
stressed that we used an extraction protocol which
preserves the chromatin intact. We hypothesize that
PCNA is not stably part of the complex, but rather
could act as a recruiting factor for chromatin binding
through physical interaction with one or more of the
components of the complex.
Several BER proteins have been shown to undergo
post-translational modiﬁcations. For example, FEN1,
XRCC1, APE1 and LIG1 are phosphorylated (reviewed
in (8)). Interestingly, in our complex we detected a protein
kinase activity, which was inhibited by p21
WAF/CIP and
was able to phosphorylate endogeneous polypeptides,
suggesting that phosphorylation can occur within the
complex itself.
The fact that the major S-phase speciﬁc cyclin A, was
physically associated to the complex together with the
major replicative enzyme POLa and with the DNA
replication protein MCM7 immediately suggests a possi-
ble link of the BER/SSBR pathway with the DNA
replication process. Recent data indicated that the
DSBR pathway is controlled by the cyclin A–cdk complex
(23) suggesting a possible model of co-regulation of repair
pathways during the cell cycle (24). A preassembled
complex containing DNA replication, cell cycle and
BER components speciﬁcally involved in endogenous
DNA damage processing (i.e. UNG2 and APE1) might
indicate the need of a repairosome for these lesions
frequently encountered by the replication machinery.
Indeed, UNG2 has been found associated to DNA
replication proteins (25–27). The present data, however,
does not allow to conclude that the isolated repairosome is
speciﬁcally formed in S-phase or exists also in other phases
of the cell cycle, such as G1 or G2. Analysis of the
dynamics of the repairosome as a function of the cell cycle
is currently underway in our laboratory. Interestingly, the
DSB repair enzyme DNAPK is also present in our BER
complex, along with XRCC1. XRCC1 has been shown to
coordinate the assembly of SSBR and BER components
at damaged sites and is essential for cells survival after
SSB induction (reviewed in (28)). In addition, recent
results suggest that XRCC1 phosphorylation by
DNA PK in response to ionizing radiation, might trigger
a signal cascade leading to NHEJ-dependent DSBR (14).
1576 Nucleic Acids Research, 2007, Vol. 35, No. 5Thus, XRCC1 appears to act as an early responder of
DNA breaks at stalled replication forks. In light of these
results, our ﬁndings raise the intriguing hypothesis that
XRCC1 and DNA- PK might be stably associated to a
repairosome, which is linked to the DNA replication fork
through association with POLa and MCM7. Depending
on the cellular context, cell cycle phase and type of
damage, this repairosome will have the ability to quickly
respond to a stalled replication fork, activating diﬀerent
DNA repair pathways.
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